Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Krystal Biotech (KRYS) Return on Sales (2021 - 2025)

Krystal Biotech's Return on Sales history spans 4 years, with the latest figure at 0.48% for Q4 2025.

  • For Q4 2025, Return on Sales fell 2.0% year-over-year to 0.48%; the TTM value through Dec 2025 reached 0.53%, up 22.0%, while the annual FY2025 figure was 0.53%, 22.0% up from the prior year.
  • Return on Sales for Q4 2025 was 0.48% at Krystal Biotech, down from 0.81% in the prior quarter.
  • Across five years, Return on Sales topped out at 46.63% in Q4 2021 and bottomed at 0.02% in Q1 2024.
  • The 4-year median for Return on Sales is 0.44% (2025), against an average of 5.84%.
  • The largest annual shift saw Return on Sales crashed -911bps in 2024 before it soared 49bps in 2025.
  • A 4-year view of Return on Sales shows it stood at 46.63% in 2021, then plummeted by -100bps to 0.21% in 2023, then skyrocketed by 142bps to 0.5% in 2024, then fell by -4bps to 0.48% in 2025.
  • Per Business Quant, the three most recent readings for KRYS's Return on Sales are 0.48% (Q4 2025), 0.81% (Q3 2025), and 0.4% (Q2 2025).